Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Avelumab With Valproic Acid in Virus-associated Cancer [Phase 2]
Phase 2 trial evaluating the PD-L1 inhibitor avelumab in combination with valproic acid for virus-associated cancers has completed; the upda…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma) [Phase 1, Phase 2]
A phase 1/2 randomized trial evaluating spermidine to prevent radiation-induced xerostomia in patients with head and neck cancers, including…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Screening for Early Diagnosis of Nose Cancer [NA]
A clinical trial sponsored by National University Hospital, Singapore is recruiting to study screening for early diagnosis of nasopharyngeal…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Their Correlation With Clinical Cognitive Scores.
A clinical trial update evaluating brain changes detected by multiplex MRI in nasopharyngeal carcinoma patients after treatment and how thes…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma [NA]
Completed clinical trial evaluating the effect of oral nutritional supplements on body weight loss in nasopharyngeal carcinoma patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Phase III Non-Inferiority Trial of Proton Versus Photon Therapy for Nasopharyngeal Carcinoma [Phase 3]
Phase III non-inferiority trial comparing proton therapy versus photon therapy for nasopharyngeal carcinoma is currently recruiting. The stu…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC [Phase 3]
Phase 3 clinical trial comparing neoadjuvant versus adjuvant treatment for locally advanced recurrent nasopharyngeal carcinoma; currently re…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating KL-A167 plus cisplatin and gemcitabine versus placebo with cisplatin and gemcitabine for recurrent or metastatic na…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial [Phase 2]
A Phase 2, single-arm clinical trial assessing the TC regimen as adjuvant therapy after surgery for locally recurrent resectable nasopharyng…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma. [Phase 3]
This clinical-trial update announces a Phase 3 study evaluating QL1706, a PD-1/CTLA-4 bispecific antibody, in combination with chemoradiothe…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating TN induction and adjuvant therapy for resectable local recurrent nasopharyngeal carcinoma is currently r…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients [Phase 3]
A Phase 3 trial evaluated the efficacy of ulinastatin to reduce radiation-induced oral mucositis in patients with nasopharyngeal carcinoma, …
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating an EGFR-targeting antibody in combination with a PD-1 inhibitor and chemotherapy for recurren…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating radiotherapy with nimotuzumab or cisplatin in nasopharyngeal carcinoma; the study is currently active but …
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Application of 18F-FDG PET/MRI for Initial Staging in Locally Advanced Nasopharyngeal Carcinoma
This clinical trial entry describes evaluating the use of 18F-FDG PET/MRI for initial staging in locally advanced nasopharyngeal carcinoma, …
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal Carcinoma [NA]
An update on a completed clinical trial studying reduced target radiotherapy for nasopharyngeal carcinoma. The study explored whether reduci…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating reduced-dose radiotherapy versus standard-dose radiotherapy for early-stage nasopharyngeal carcinoma; curr…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma [NA]
UCSF-sponsored study on induction chemotherapy response-guided radiation for EBV-associated nasopharyngeal carcinoma is currently recruiting…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Evaluation of Swallowing Muscles Using Ultrasonography and Shear Wave Elastography in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma Diagnosis
Clinical trial update on evaluating swallowing muscles using ultrasonography and shear wave elastography in patients receiving radiotherapy …
-
CLINICAL_TRIALS other · 2025-04-13Clinical Trial Update: A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial update for Penpulimab (AK105) in the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma. The st…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC [Phase 3]
A Phase 3 clinical trial evaluating optimized prophylactic radiotherapy to preserve thyroid function in nasopharyngeal carcinoma is currentl…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
This Clinical Trial Update describes a Phase II randomized, double-blind, placebo-controlled multicenter study evaluating Nituzumab (Taixins…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating sintilimab plus capecitabine as adjuvant therapy for high-risk nasopharyngeal carcinoma; the trial status …
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating chemotherapy with or without toripalimab for primary metastatic nasopharyngeal carcinoma; the study is active but n…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain [Phase 3]
Update on a Phase 3 trial evaluating reduced-dose versus standard-dose radiotherapy for nasopharyngeal carcinoma. The study is sponsored by …